Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol.
Kainuma M, Funakoshi K, Ouma S, Yamashita KI, Ohara T, Yoshiiwa A, Murata M, Tsuboi Y. Kainuma M, et al. Among authors: yamashita ki. Medicine (Baltimore). 2020 Sep 18;99(38):e22370. doi: 10.1097/MD.0000000000022370. Medicine (Baltimore). 2020. PMID: 32957414 Free PMC article.
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: yamashita ki. Front Pharmacol. 2022 Oct 14;13:991982. doi: 10.3389/fphar.2022.991982. eCollection 2022. Front Pharmacol. 2022. PMID: 36313371 Free PMC article.
Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan.
Kainuma M, Kawakatsu S, Kim JD, Ouma S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Kainuma M, et al. Among authors: yamashita ki. Front Pharmacol. 2023 Jun 12;14:1203349. doi: 10.3389/fphar.2023.1203349. eCollection 2023. Front Pharmacol. 2023. PMID: 37377927 Free PMC article.
Functional connectivity change between posterior cingulate cortex and ventral attention network relates to the impairment of orientation for time in Alzheimer's disease patients.
Yamashita KI, Uehara T, Prawiroharjo P, Yamashita K, Togao O, Hiwatashi A, Taniwaki Y, Utsunomiya H, Matsushita T, Yamasaki R, Kira JI. Yamashita KI, et al. Among authors: yamashita k. Brain Imaging Behav. 2019 Feb;13(1):154-161. doi: 10.1007/s11682-018-9860-x. Brain Imaging Behav. 2019. PMID: 29644521
45 results